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Alternative splicing from a single gene produces four kinds of human tyrosine hydroxylase (types l-4), which have struc- 
tural diversity only in the N-terminal region. We attempted expression of the type l-4 enzymes in COS cells and per- 
formed kinetic analyses. All had enzymatic activities. The K, values of the four types for L-tyrosine and 6-methyl-5,6,7,8- 
tetrahydropteridine were similar, although their relative homospecific activities were clearly different. The type 1 enzyme 
displayed the highest activity. 
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1. INTRODUCTION 
Tyrosine hydroxylase (TH, EC 1.14.16.2) is a 
monooxygenase that catalyzes the conversion of L- 
tyrosine to 3,4_dihydroxyphenylalanine (DOPA), 
requiring pteridine as a cofactor. TH is the first 
and rate-limiting enzyme in the pathway of 
catecholamine biosynthesis, its enzyme activity be- 
ing regulated by protein phosphorylation [ 1,2] and 
by some organic compounds [3-51. Recently, four 
types of human TH (types l-4) have been found 
by cDNA cloning [6-81. This protein diversity is 
generated through alternative splicing from a 
single gene [9- 111. This alternative splicing causes 
insertion/deletion of the short amino acid se- 
quences in the N-terminal region of TH. The type 
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2 and 3 enzymes have sequences of 4 and 27 amino 
acids, respectively, between amino acids 30 and 3 1 
of the type 1 enzyme. The type 4 enzyme has both 
the 4 and 27 amino acid sequences at the same 
position. Tissue- and stage-specific expression of 
different TH molecules has been reported [6,10], 
suggesting that alternative splicing plays an impor- 
tant role in functioning of TH. The functional dif- 
ferences among these TH types should be of 
interest, We attempted the transient expression of 
these four types of human TH, using a mammalian 
cell line, to compare their enzymatic properties. 
2. MATERIALS AND METHODS 
2.1. Vector construction 
The full-length cDNA clones encoding human TH types l-4 
were isolated from human pheochromocytoma cDNA library as 
described in our previous papers [7,8]. pAGEl [12] and pL1 
[13] have been described. Expression vectors PAS-TH l-4, hav- 
ing human TH type l-4 cDNAs, respectively, were constructed 
as follows: the HindIII-BgllI 4.1 kb fragment from pAGEl 
(the BgnI site was modified with the EcoRI linker) was con- 
nected with the HindIII-PstI 0.5 kb fragment from pL1 (the 
PstI site was modified with the JZcoRI linker). The resulting 
plasmid, PAS, has the SV40 origin and promoter downstream 
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of the ecotropic Maloney virus (ECO-MOL) long terminal 
repeat (LTR). The EcoRI-EcoRI fragments containing the four 
types of cDNA were inserted into the EcoRI site of PAS. 
2.2. DNA transfection 
2 x lo6 COS cells (COS l), freshly grown in 10 ml Dulbecco’s 
modified Eagle’s medium/l0 cm dish, were transfected with 
10 tg plasmid DNA by the calcium phosphate coprecipitation 
method [14]. Glycerol shock [15] was performed for 2 min, 4 h 
after transfection. The cells were harvested after 3 days. 
2.3. Preparation of cell extracts 
Cell extracts were prepared from 10’ cells (5 dishes), by 
sonication in 500 /tl of 50 mM potassium phosphate buffer (pH 
7.3), containing 320 mM sucrose, 1 mM EDTA, 1 mM DTT, 
leupeptin 1 mg/ml, pepstatin 1 mg/ml, and 0.2 mM 
phenylmethylsulfonyl f uoride, followed by centrifugation for 
10 min at 10000 x g. Protein concentration was determined us- 
ing a Bio-Rad protein assay kit with bovine serum albumin as 
a standard [16]. 
2.4. Western blotting 
After SDS-PAGE [17], proteins were transferred to a 
nitrocellulose membrane (Bio-Rad). The membrane was in- 
cubated with anti-rat TH antibody (1: 100 dilution). Im- 
munoreactive proteins were detected using a Bio-Rad 
immunostaining kit with horseradish peroxidase (HRP)- 
conjugated anti-rabbit IgG or using ‘251-labeled anti-rabbit IgG 
(Amersham). 
2.5. Assay of TH activity 
TH activity was determined based on the measurement of 
DOPA formed from L-tyrosine by HPLC with electrochemical 
detection as in [18]. The cell extract was incubated in 200~1 of 
the standard reaction mixture: 0.2 M sodium acetate buffer (pH 
6.0), containing 0.1 M 2-mercaptoethanol, 0.2 mg/ml catalase, 
1 mM 6-methyl-5,6,7,8_tetrahydropteridine (6-MPH4) and 
0.2 mM L-tyrosine. Incubation was carried out for 10 min at 
37°C. For kinetic analysis, TH activities were assayed at various 
concentrations of either L-tyrosine or 6-MPH4. Kinetic con- 
stants were determined by Lineweaver-Burk analysis. The 
relative homospecific activities (activity per enzyme protein 
[19]) were estimated as follows: to determine the relative 
amounts of the four enzymes in cell extracts, Western blotting 
was carried out with anti-rat TH antibody and ‘*?-labeled anti- 
rabbit IgG. The intensities of TH bands on the autoradiogram 
were determined using a densitometer (Shimadzu). The ac- 
tivities of the type l-4 enzymes were divided by the relative 
amounts of the proteins. 
3. RESULTS AND DISCUSSION 
Fig.1 illustrates the expression vector. After 
DNA transfection, COS cell extracts were 
prepared and analyzed by Western blotting (fig.2). 
Cells transfected with each of PAS-TH l-4 gave 
major immunoreactive bands at 61, 61, 65 and 
65 kDa, respectively. The pBR322-transfected cells 
did not produce these bands. Thus, these bands 
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Fig. 1. Structure of PAS-TH 1. The ECO-MOL LTR (LTR) and 
the SV40 origin/promoter (SV40) are indicated by the hatched 
areas. The SV40 polyadenylation signal (poly A), splice 
donor/acceptor sites (ss), pBR322 replication origin (ori) and 
kanamycin-resistance gene (Km3 are shown. Unfilled areas 
indicate the 5 ‘- and 3 ‘-untranslated regions of human TH type 
1 cDNA; the filled area represents its coding region. In PAS-TH 
2-4, the EcoRI-EcoRI fragment containing the type 1 cDNA is 
exchanged by the corresponding cDNA fragments. E, EcoRI; 
H, HindIII; C, ClaI. 
correspond to the type l-4 enzymes, respectively. 
The molecular masses estimated from SDS-PAGE 
were similar to those predicted from the cDNA se- 
quences [6-81. We assayed TH activities in cell ex- 
tracts. As shown in table 1, cells transfected with 
each of PAS-TH l-4 showed TH activity whereas 
pBR322-transfected cells exhibited none. This in- 
dicates that all four types of human TH have en- 
zymatic activity. 
Table 1 summarizes the results of kinetic 
analysis. The K,,, values for L-tyrosine ranged from 
-100 to -250,uM, those for B-MPH4 being from 
-180 to -250 PM. The K, values for L-tyrosine 
are similar to those obtained from the purified rat 
[20] and bovine [21] enzymes. The low-affinity 
form of TH to pteridine (Km -200 PM) reportedly 
changes to the high-affinity form (K,,, -2OpM) 
through protein phosphorylation [22,23]. The K,,, 
values for 6-MPH4 suggest hat the four types of 
TH may exist as the low-affinity form in COS 
cells. Recently, Ginns et al. [24] have reported ex- 
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Fig.2. Western blotting of expression products. Cell extracts 
(-100 pg) from COS cells transfected with pBR322 (A), PAS- 
TH 1 (B), PAS-TH 2 (C), PAS-TH 3 (D), PAS-TH 4 (E), and 
purified bovine TH (F) were electrophoresed on a 10% SDS- 
polyacrylamide gel. Western blotting was carried out with anti- 
rat TH antibody and HRP-conjugated anti-rabbit IgG. 
Molecular mass standards: phosphorylase b, bovine serum 
albumin, ovalbumin, carbonic anhydrase, and soybean trypsin 
inhibitor. 
pression of human TH type 2 using a baculovirus 
vector. The results of their kinetic analysis are 
similar to ours. 
We also estimated the relative homospecific ac- 
tivities (table 1). The type 1 enzyme had the highest 
homospecific activity, the values for the other en- 
zymes ranging from -0.3 to -0.4. The insertion se- 
quences eem to inhibit the TH activity. Mogi et al. 
[25] have reported the existence of the active form 
(form 1) and inactive or less active type (form 2) of 
human TH in adrenal medulla [25]. Both forms 
have similar molecular masses (-60 kDa), but the 
homospecific activity of form 2 is clearly lower 
than that of form 1. Comparison of the enzymatic 
properties of the four types suggests that types 1 
and 2 may correspond to forms 1 and 2, respective- 
ly, or form 2 could be produced by some modifica- 
tions and not be due to the differences between the 
TH types. 
The N- and C-terminal half regions of TH are 
the regulatory and catalytic domains, respectively 
[26]. The major phosphorylation sites of some pro- 
tein kinases have been identified in the N-terminal 
region of rat TH [27,28]. Cyclic AMP-dependent 
protein kinase mainly phosphorylates Ser 40. 
Ca”/calmodulin-dependent protein kinase II 
phosphorylates both Ser 19 and Ser 40. These Ser 
residues are conserved between rat TH and the 
type 1 enzyme of human TH. Since the insertion 
sequences characteristic to the type 2-4 enzymes of 
human TH exist near these major phosphorylation 
sites, it has been suggested that the sequence diver- 
sity may affect the regulatory mechanism of the 
enzymatic activity through protein phosphoryla- 
tion. Moreover, TH is regulated by some organic 
compounds, such as polyanions [3,4], phospho- 
lipids [3], and catecholamines [4,5], which may be 
involved in the functional differences among the 
TH types. 
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Table 1 
Kinetic constants and relative homospecific activities of the four types of human 
TH 
Enzyme V,,, (pmol/min per mg Relative 
type (/I&a protein) homospecific 
activityb 
L-Tyrosine 6-MPH4 L-Tyrosine 6-MPH4 
1 105 + 15 253 + 69 58.1 + 5.1 57.6 + 9.8 1.00 
2 159 f 43 254 * 36 44.7 + 4.3 26.0 2 2.3 0.40 
3 148 + 34 182 k 69 19.9 * 3.3 12.4 & 2.4 0.31 
4 253 2 71 191 + 39 75.4 f 2.3 44.6 + 5.0 0.26 
a Average k SE 
b Ratio vs homospecific activity of the type 1 enzyme 
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